CHIAVARINI, Milena
 Distribuzione geografica
Continente #
EU - Europa 1.505
NA - Nord America 1.490
AS - Asia 528
SA - Sud America 5
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.531
Nazione #
US - Stati Uniti d'America 1.455
CN - Cina 426
FI - Finlandia 347
SE - Svezia 297
IE - Irlanda 255
UA - Ucraina 193
IT - Italia 169
DE - Germania 157
TR - Turchia 79
GB - Regno Unito 36
CA - Canada 34
BE - Belgio 19
AT - Austria 12
IN - India 7
SG - Singapore 7
IR - Iran 6
AR - Argentina 5
CZ - Repubblica Ceca 5
ES - Italia 4
FR - Francia 3
LU - Lussemburgo 2
NL - Olanda 2
AU - Australia 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
KR - Corea 1
KZ - Kazakistan 1
PA - Panama 1
PH - Filippine 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 3.531
Città #
Dublin 255
Chandler 252
Jacksonville 252
Dearborn 143
Ann Arbor 108
Beijing 102
Ashburn 91
Izmir 75
Nanjing 66
Princeton 51
San Mateo 48
Toronto 33
New York 32
Bremen 31
Wilmington 29
Helsinki 25
Hebei 24
Shanghai 24
Nanchang 23
Des Moines 20
Grafing 20
Kunming 20
Boardman 19
Brussels 19
Jinan 19
Shenyang 18
Tianjin 16
Woodbridge 16
Guangzhou 15
Parma 15
Hefei 13
Milan 12
Vienna 12
Changsha 10
Auburn Hills 8
Haikou 8
Hangzhou 6
Jiaxing 6
Mordano 6
Seattle 6
Cordoba 5
Los Angeles 5
Prague 5
Taiyuan 5
Fuzhou 4
Kocaeli 4
Augusta 3
Bologna 3
Chengdu 3
Dallas 3
Houston 3
Mondolfo 3
Monzambano 3
Ningbo 3
Norwalk 3
Taizhou 3
Ardabil 2
Atlanta 2
Bari 2
Collegno 2
Fiorano Modenese 2
Fremont 2
Jinhua 2
Luxembourg 2
Madrid 2
Monmouth Junction 2
Mountain View 2
Paris 2
Piacenza 2
Rockville 2
Sabz 2
San Severo 2
Shaoxing 2
Abano Terme 1
Amsterdam 1
Ascoli Piceno 1
Avezzano 1
Baotou 1
Bend 1
Birmingham 1
Borås 1
Boston 1
Brescia 1
Brisbane 1
Bucharest 1
Cagliari 1
Capannoli 1
Carini 1
Carpi 1
Castell'arquato 1
Catania 1
Cesena 1
Changchun 1
Chicago 1
Chongqing 1
Delhi 1
Edinburgh 1
Florence 1
Forlì 1
Frankfurt am Main 1
Totale 2.067
Nome #
Principi di farmacognosia e fitoterapia 206
Antinociceptive and gastroprotective effects of inhaled and orally administered Lavandula hybrida Reverchon “Grosso” essential oil 98
Caratterizzazione farmacologica in vitro di nuovi agonisti muscarinici analoghi dell'Oxotremorina 98
Azionifarmacologiche di composti alchilaminoalchilfenilbenzisotiazolici sul trattogastrointestinale 98
Comparison of the effects of structurally different H2-antagonists on acid and pepsin activity stimulated by dimaprit in conscious cats 97
Analgesic properties of benzisothiazole/ benzimidazole derivatives with acidic groups 94
Influence of adenosine in the systemic and local injury caused by mesenteric ischemia-reperfusion in mice 87
Regional differences in motor responsiveness to antimuscarinic drugs in rabbit isolated small and large intestine 85
Analgesici-antipiretici benzopirano pirimidinici non acidici attivi per via orale privi di gastrolesività 85
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 82
Buovi potenti agonisti muscarinici oxotremorina-M-simili a struttura acetilenica: studio funzionale in vitro 79
Synthesis and pharmacological screening of novel non-acidic gastric-sparing antiinflammatory/antiplatelet agents:5-alkyl/cycloalkylamino substituted 2-amino-5H-[1]benzopyrano[4,3-d]pyrimidines 78
4-(1,2-benzisothiazol-3-)alkanoic and phenylalkanoic acids: synthesis and anti-inflammatory, analgesic and antipyretic activities 75
Novel antiplatelet and antithrombotic activities of essential oil from Lavandula hybrida Reverchon "Grosso" 74
Synthesis and functional characterization of novel heterocyclic derivatives related to oxotremorine and oxotremorine-M 74
Different role of the Histamine H3 Receptor in Vagal-, Betanechol-, Pentagastrin-induced Gastric Acid Secretion in Anaesthetized Rats 73
Functional Studies of New Imidazole H3-Antagonists on Guinea-Pig Isolated Preparations 71
H2-receptor antagonist activity of N-methylthiourea, N-cyano-N'-methylguanidine, N-cyanoamidine, N-carbamoylamidine and N-sulfamoylamidine 5-substituted thiazole derivatives on guinea-pig atria. 70
Effects of antimuscarinic agents, H2-blockers and omeprazole on rat chronic gastric ulcer after long-a and short-term administration 69
Antiulcer long-term treatment in chronic ulcer rat 67
Screening di nuovi agenti antiinfiammatori/antiaggreganti non-acidici: sviluppo di 2-amino-5H-[1]benzopirano[4,3-d]pirimidine 5-alchil/cicloalchilamino sostituite prive di attivita' gastrolesiva 67
New potent acethylenic muscarinic agonists related to oxotremorine-M: in vitro functional study 67
4-(3-Oxo-1,2-benzisothiazolin-2-yl)alkanoic, phenyl and phenoxyalkanoic acids: synthesis and anti-inflammatory, analgesic, and antipyretic properties 66
Functional comparison between nuvenzepine and pirenzepine on different guinea pig isolated smooth muscle preparations 66
A possible physiological role ofhistamine H^-receptors in rat mesenteric circulation 66
Hz-agonistiimidazolici: importanza della 2-amino sostituzione per 1'attivita farmacologica 66
Sviluppo e caratterizzazione farmacologica di un nuovo potente e selettivo H3-bloccante istaminico non-tioureico 65
Synthesis and pharmacological evaluation of 2,5-cycloamino-5H-[1]benzopyrano-[4,3-di]pyrimidines endowed with in vitro antiplatelet activity 64
Pharmacological activities of two new histamine analogs 62
Comparative screening of plant essential oils: phenylpropanoid moiety as basic core for antiplatelet activity 62
Inflammatory response and intestinal dismotility caused by experimental ischemia/reperfusion injury in rats: possible involvement of NMDA receptors 61
Effects of H2-blockers on rat mesenteric arterioles under resting conditions. 61
Orally active non-acidic analgesic-antipyretic benzopyranopyrimidines devoided of gastrolesivity 61
null 61
Novel triazolonaphthyridine derivatives: potent and highly effective agents in the control of inflammation and pain in rodents 60
Functional plasticity of rat intestine after removal of chronic mechanical obstruction 59
Pharmacological characterization of new antiplatelet benzopyrano[4,3-d]pyrimidines 59
Protective and antisecretory effects of the new PGE2 analogue, FCE 20700, and of 16,16 dimethylPGE2 in pylorus-ligated rats 56
Selectivity study of new potent H3-blockers in electrically-stimulated and non-stimulated guinea-pig ileum 55
Inhibitory effect of intracranial injections of tachykinins on angiotensin-induced drinking in the cat. 54
Rat gastric acid secretion: functional evidence for a role of h3 histamine receptors 53
New muscarinic analgesics: in vivo pharmacological profile 53
Influence of urea-equivalent groups in position 5 of 2-amino, 2-(1-aminoethylidenamino) and 2-guanidino thiazole derivatives on H3-receptor antagonist activity in gastric fistula cat 53
New polycyclic pyrimidine derivatives with antiplatelet in vitro activity: synthesis and pharmacological screening 52
Pharmacological characterization of H3 receptor antagonists with imidazole, thioimidazole and thioimidazoline polar groups in the side chain 51
Gastrointestinal activities of a new pirenzepine-analog, nuvenzepine, in the cat. 49
Structural analogues of thioperamide: pharmacological evaluation of new benzothiazole derivatives at peripheral histamine receptor subtypes 46
Synthesis and preliminary pharmacological study of new amidinobenzisothiazoles 45
The effect of long-term treatment with antisecretory and antiulcer drugs on gastric secretory and motor responsiveness to caerulein in rats with chronic ulcers 45
Pharmacological screening of novel antiplatelet agents with analgesic activity 43
In vivo preliminary evaluation of the antithrombotic activity of benzopyranopyrimidines with in vitro antiplatelet effects 42
Are histamine receptors involved in the stimulant activities ofthiazolylethylamines supposed as cyclic models of dimaprit? 7
Totale 3.537
Categoria #
all - tutte 10.155
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.155


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019120 0 0 0 0 0 0 0 0 0 12 100 8
2019/2020869 124 111 68 16 74 102 107 18 112 35 46 56
2020/2021412 10 56 35 3 49 2 47 3 97 16 89 5
2021/2022299 7 3 2 26 18 32 41 42 19 18 13 78
2022/20231.039 107 109 76 67 124 118 7 68 314 7 29 13
2023/2024252 24 31 2 7 25 76 56 16 11 4 0 0
Totale 3.537